+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Interleukin"

From
From
Interleukin Inhibitors Market Report 2025 - Product Thumbnail Image

Interleukin Inhibitors Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Psoriatic Arthritis Treatment Market Report 2025 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Arthritis Monoclonal Antibodies Market Report 2025 - Product Thumbnail Image

Arthritis Monoclonal Antibodies Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market Report 2025 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market Report 2025 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anakinra Global Market Report 2025 - Product Thumbnail Image

Anakinra Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Anti-Inflammatory Drugs Global Market Report 2025 - Product Thumbnail Image

Anti-Inflammatory Drugs Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
From
Loading Indicator

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases. In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more